Diabetes pumps
March 13, 2013
THERE is clear evidence that use
of insulin pumps improves HbA1c in
adults and children with type 1
diabetes, according to the
Australian Diabetes Society.
The comment is part of the
organisation’s submission to the
Department of Health’s public
consultation on the Post Market
Review of Products Used in the
Management of Diabetes Stage
Two: Insulin Pumps.
“Hypoglycaemia was not
increased in those studies, and in
some studies was significantly
decreased despite lower HbA1c,”
the submission said.
“In the STAR3 trial, HbA1c
improved 0.7-0.8%, which is
roughly comparable to the
improvement in the DCCT study.
“Improved glucose control in the
DCCT study decreased new onset
or progression of diabetes
complications by 39-76%,” the
submission added.
In addition, the Society said that
insulin pumps compare well for
cost per quality of life year gained
when compared to multiple daily
injections.
The above article was sent to subscribers in Pharmacy Daily's issue from 13 Mar 13To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 13 Mar 13
